Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,902,900 | 1,408,800 | 4,474,000 | 3,529,100 | 2,086,200 |
| Depreciation Amortization | 238,100 | 121,100 | 650,500 | 686,900 | 340,400 |
| Income taxes - deferred | 71,600 | 228,000 | 108,300 | -44,800 | -57,400 |
| Accounts receivable | -2,900 | -136,600 | -205,200 | -254,000 | -187,200 |
| Other Working Capital | 116,300 | -146,800 | 400,200 | 49,400 | -21,900 |
| Other Operating Activity | 97,500 | -15,000 | 759,900 | 325,700 | 396,300 |
| Operating Cash Flow | $3,423,500 | $1,459,500 | $6,187,700 | $4,292,300 | $2,556,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -314,000 | -127,100 | -770,600 | -544,700 | -381,500 |
| Net Acquisitions | -1,044,400 | -300,000 | -1,962,900 | -1,775,400 | -1,362,900 |
| Purchase Of Investment | -2,075,100 | -825,000 | -8,371,399 | -6,093,800 | -4,774,300 |
| Sale Of Investment | 3,565,500 | 1,489,200 | 9,173,700 | 7,994,700 | 6,802,700 |
| Purchase Sale Intangibles | 0 | 0 | -115,500 | -3,000 | -88,000 |
| Other Investing Activity | -4,000 | 1,700 | -115,101 | -1,800 | -85,900 |
| Investing Cash Flow | $128,000 | $238,800 | $-2,046,300 | $-421,000 | $198,100 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,200 | -3,200 | N/A |
| Common Stock Issued | -23,600 | -32,200 | N/A | -6,700 | -14,300 |
| Common Stock Repurchased | -3,057,300 | -655,800 | -4,352,600 | -3,000,000 | -3,000,000 |
| Other Financing Activity | 25,900 | 8,700 | -116,200 | -25,100 | -45,800 |
| Financing Cash Flow | $-3,055,000 | $-679,300 | $-4,472,000 | $-3,035,000 | $-3,060,100 |
| Exchange Rate Effect | 2,300 | -400 | -18,600 | -23,400 | -18,000 |
| Beginning Cash Position | 1,224,600 | 1,224,600 | 1,573,800 | 1,573,800 | 1,573,800 |
| End Cash Position | 1,723,400 | 2,243,200 | 1,224,600 | 2,386,700 | 1,250,200 |
| Net Cash Flow | $498,800 | $1,018,600 | $-349,200 | $812,900 | $-323,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,423,500 | 1,459,500 | 6,187,700 | 4,292,300 | 2,556,400 |
| Capital Expenditure | -314,000 | -127,100 | -770,600 | -544,700 | -381,500 |
| Free Cash Flow | 3,109,500 | 1,332,400 | 5,417,100 | 3,747,600 | 2,174,900 |